Targeting NRF2 signaling for cancer chemoprevention
- 1 April 2010
- journal article
- review article
- Published by Elsevier BV in Toxicology and Applied Pharmacology
- Vol. 244 (1), 66-76
- https://doi.org/10.1016/j.taap.2009.08.028
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Genetic versus chemoprotective activation of Nrf2 signaling: overlapping yet distinct gene expression profiles between Keap1 knockout and triterpenoid-treated miceCarcinogenesis: Integrative Cancer Research, 2009
- Chemical genomics of cancer chemopreventive dithiolethionesCarcinogenesis: Integrative Cancer Research, 2009
- Targeting Nrf2 with the triterpenoid CDDO- imidazolide attenuates cigarette smoke-induced emphysema and cardiac dysfunction in miceProceedings of the National Academy of Sciences of the United States of America, 2009
- Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancyProceedings of the National Academy of Sciences of the United States of America, 2008
- Molecular mechanisms of Nrf2‐mediated antioxidant responseMolecular Carcinogenesis, 2008
- Impaired liver regeneration in Nrf2 knockout mice: role of ROS-mediated insulin/IGF-1 resistanceThe EMBO Journal, 2007
- Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: A systematic review and meta-analysisEuropean Journal of Cancer, 2005
- Cancer chemoprevention with dietary phytochemicalsNature Reviews Cancer, 2003
- Inflammation and cancerNature, 2002
- Chemopreventive activity of Oltipraz against N-nitrosobis(2-oxopropyl)amine (BOP)-induced ductal pancreatic carcinoma development and effects on survival of Syrian golden hamstersCarcinogenesis: Integrative Cancer Research, 1995